Tilatamig samrotecan

Tilatamig samrotecan
SKU
MEXHY-171124-0
Packaging Unit
Get quote
Manufacturer
MedChemExpress

Availability: loading...
Price is loading...
Product Description: Tilatamig samrotecan (AZD9592) is an antibody-drug conjugate (ADC) used to deliver topoisomerase I inhibitors (TOP1i), targeting the epidermal growth factor receptor (EGFR) and c-MET, with anti-tumor activity. Tilatamig samrotecan (AZD9592) can induce DNA double-strand breaks, increase the expression of pRAD50 and γH2AX, and inhibit the growth of non-small cell lung cancer[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Lara McGrath, et al. Abstract 5737: Evaluation of the relationship between target expression and in vivo anti-tumor efficacy of AZD9592, an EGFR/c-MET targeted bispecific antibody drug conjugate. Cancer research. (2023) 83 (7_Supplement): 5737./[2]Kinsley Wang, et al. Anti-MET Antibody Therapies in Non-Small-Cell Lung Cancer: Current Progress and Future Directions. Antibodies (Basel). 2024 Oct 18;13(4):88.

Molecular Weight: N/A

Research Area: Cancer

Target: DNA/RNA Synthesis;Topoisomerase
More Information
SKU MEXHY-171124-0
Manufacturer MedChemExpress
Manufacturer SKU HY-171124-0
Package Unit Get quote
Quantity Unit STK
Product information (PDF)
×
MSDS (PDF)
×